ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Synthetic Biologics Inc

Synthetic Biologics Inc (SYN)

1.02
0.00
(0.00%)
Closed September 19 4:00PM
1.02
0.00
( 0.00% )
Pre Market: 8:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
1.02
Bid
-
Ask
-
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.02
Open
-
Last Trade
Last Trade Time
-
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
17,043,000
Dividend Yield
-
PE Ratio
-3.52
Earnings Per Share (EPS)
-1.08
Revenue
-
Net Profit
-18.35M

About Synthetic Biologics Inc

Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbio... Synthetic Biologics is a late-stage biotechnology company focused on developing gut microbiome therapeutics. Its portfolio includes SYN-010, which is intended to treat the underlying causes of irritable bowel syndrome with constipation; and SYN-004 (ribaxamase), which aims to defend the gut microbiome from the effects of regularly used intravenous drugs for the prevention of C. difficile infection, antibiotic-associated diarrhea, and the emergence of antibiotic-resistant organisms. The company is also developing monoclonal antibody therapies for the treatment of pertussis and novel discovery stage biotherapeutics for the treatment of phenylketonuria. Show more

Sector
Pharmaceutical Preparations
Industry
Business Services
Headquarters
Rockville, Maryland, USA
Founded
1993

SYN Latest News

Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference

Synthetic Biologics to Present at 2022 BIO CEO & Investor Conference PR Newswire ROCKVILLE, Md., Feb. 9, 2022 ROCKVILLE, Md., Feb. 9, 2022 /PRNewswire/ -- Synthetic Biologics, Inc. (NYSE...

Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA

Synthetic Biologics Announces VCN Biosciences' VCN-01 Receives Orphan Drug Designation for Retinoblastoma from the U.S. FDA Follows recent announcement of planned acquisition of VCN Biosciences...

Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022

Synthetic Biologics to Present at the B. Riley Securities Oncology Conference on January 28, 2022 PR Newswire ROCKVILLE, Md., Jan. 26, 2022 ROCKVILLE, Md., Jan. 26, 2022 /PRNewswire/ -- Synthetic...

Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors

Synthetic Biologics Announces Planned Transformative Acquisition of VCN Biosciences; Developer of a Novel Oncolytic Virus Platform Targeting Pancreatic and other Solid Tumors Lead drug candidate...

Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

Synthetic Biologics Reports Third Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Initiated a Phase 1 Multiple Ascending Dose Clinical...

Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021

Synthetic Biologics to Report 2021 Third Quarter Operational Highlights and Financial Results on November 3, 2021 -- Conference Call Scheduled for Wednesday, November 3, 2021 at 4:30 p.m. ET...

Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase

Synthetic Biologics Announces Initiation of a Phase 1 Multiple-Ascending Dose Clinical Trial for SYN-020 Intestinal Alkaline Phosphatase Topline Data Readout Expected in Q2 2022 Phase 1 Clinical...

Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

Synthetic Biologics Announces Second Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum The Company Encourages All Shareholders of Record Who Have Not Yet Voted to Do So by...

Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum

Synthetic Biologics Announces Adjournment of Annual Meeting of Shareholders Due to Lack of Quorum PR Newswire ROCKVILLE, Md., Sept. 21, 2021 ROCKVILLE, Md., Sept. 21, 2021 /PRNewswire/...

Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET

Synthetic Biologics Reports Second Quarter 2021 Operational Highlights and Financial Results; Conference Call to be Held Today at 4:30 PM ET Phase 1 Single-Ascending Dose Clinical Trial of...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BATLBattalion Oil Corporation
$ 6.46
(119.73%)
73.31k
IRVHGlobal X Interest Rate Volatility and Inflation Hedge ETF
$ 34.09
(58.96%)
66
PWPower REIT
$ 1.20
(16.50%)
15
AEONAEON Biopharma Inc
$ 0.7325
(9.49%)
4.73k
PEJInvesco Leisure and Entertainment ETF
$ 51.74
(8.61%)
1
SGNSigning Day Sports Inc
$ 0.3762
(-29.02%)
866.04k
ATCHAtlasClear Holdings Inc
$ 0.1611
(-11.29%)
2.07k
MTNBMatinas Biopharma Holdings Inc
$ 3.39
(-10.08%)
6
HCWCHealthy Choice Wellness Corp
$ 2.75
(-7.41%)
24.3k
ETHDProshares Ultrashort Ether ETF
$ 60.00
(-6.60%)
467
SOXLDirexion Daily Semiconductor Bull 3X Shares
$ 34.20
(-2.62%)
1.81M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
$ 22.34
(2.76%)
1.38M
SGNSigning Day Sports Inc
$ 0.3762
(-29.02%)
866.04k
TZADirexion Daily Small Cap Bear 3X Share New
$ 13.31
(0.99%)
331.04k
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
$ 5.075
(1.81%)
325.31k

Discussion

View Full Feed
$5.95akadawson-m $5.95akadawson-m 7 minutes ago
Look in your email box. Gulp. Company is pushing for a reverse split 1:30. Game over yet again.
FCEL
Methinks Methinks 8 minutes ago
https://www.bbc.co.uk/news/articles/cd7x5q39z77o
Come on - protect the kids! Use Wave.
Methinks Methinks 9 minutes ago
https://www.mishcon.com/news/mishcon-de-reya-becomes-the-first-law-firm-to-be-an-ncsc-cyber-incident-response-assured-service-provider
But are they dealing with Wave?
DP1011 DP1011 10 minutes ago
Massive sell off, oh the humanity..🫣🧐
PHIL
TrendTrade2016 TrendTrade2016 12 minutes ago
BNZI...LETS SEE IT HOLD 5.00 INTO REG PRE TRADING
BNZI
Methinks Methinks 12 minutes ago
https://securityboulevard.com/2024/09/the-supply-chain-conspiracy-cyber-attacks-behind-the-lebanon-explosions/
Could these attacks have taken place because there is a fundamental change about to happen in the cyber industry?
Ribo Ribo 12 minutes ago
First of 2 updates.
https://x.com/IDVVcorp/status/1836432708312207474
IDVV
TrendTrade2016 TrendTrade2016 14 minutes ago
FAKE BID LIKE ASII BEFORE IT GOT DUMPED TO .0009 THIS IS NEXT AND YOU WILL NEVER SEE IT TRADE AGAIN FOR ANOTHER YEAR UNTIL NEXT FAKE PLOT
ASII
ShawnP123 ShawnP123 16 minutes ago
Doesn't look good for today. Looks like it's gonna lose a lot of yesterday's gain. I still don't feel this stock will get above 120 for some time. Maybe in May or June of 2025. Market isn't going to be happy with just beating estimates. They still expect huge estimate beats which isn't realistic. Mo
NVDA
tw0122 tw0122 18 minutes ago
GDHG and BNZI
BNZI GDHG
tw0122 tw0122 19 minutes ago
Let’s get going $4.40s +!73%
GDHG
Horseb4CarT Horseb4CarT 22 minutes ago
DCVax costs of patient care for many cancers should be significantly less than the overall costs of patient care for current cancer treatments.

The current cancer treatments are costly for the actual treatment plus costly to address all the recurring labs, emergency room visits and h
NWBO
TCI1 TCI1 26 minutes ago
Thanks Captain. Slow and steady, at least the trend is good and compounding will give a value on the UK market. If we could get a bit of a bump in scripts around London/South east area that would help greatly.
AMRN
Gusher405 Gusher405 28 minutes ago
So again for those in the back. That person has been accused by the ‘critics’ as being in management and being Linda. Even though denied constantly here. Proof from the ‘critics’ is posters writing style and big words that are used. If yall have definitive info, prove it. Stop with BS.
P
DBMM
TrendTrade2016 TrendTrade2016 31 minutes ago
GDHG POST SPLIT MINI MONSTER...RS STOCKS CONTINUE TO BLOW UP
GDHG
TheFinalCD TheFinalCD 31 minutes ago
2nd News https://x.com/Flashalert40064/status/1837053718274978243


https://www.globenewswire.com/news-release/2024/09/19/2948917/0/en/Banzai-Announces-Reverse-Split-to-Regain-NASDAQ-Compliance.html

https://finviz.com/quote.ashx?t=BNZI&p=d

https://d
BNZI
knrorrel knrorrel 32 minutes ago
we need break .50
imo
AEMD
TrendTrade2016 TrendTrade2016 33 minutes ago
BNZI POST SPLIT MONSTER
BNZI
knrorrel knrorrel 33 minutes ago
nice News Yesterday
AEMD
knrorrel knrorrel 34 minutes ago
AEMD watch
AEMD
axelvento axelvento 34 minutes ago
With Pfizer hitting a stumbling block, Moderna’s COVID-19/influenza vaccine, mRNA-1083, could be the first such combination vaccine to reach the market. In June, the company posted results from a Phase III trial that showed mRNA-1083 produced a strong immune response against both COVID-19 and influe
MRNA
Ranb2khz Ranb2khz 37 minutes ago
Perfectly Loved – Rachael Lampa (feat. TobyMac) [Lyric Video]

[yt]k1IpEhuq9dU[/yt]

https://www.youtube.com/watch?v=k1IpEhuq9dU






ksquared ksquared 39 minutes ago
And now it's your turn. Happy Birthday, sdheart ! ! !
Here's to your health and longevity.
Enjoy the day and many years to come.
TrendTrade2016 TrendTrade2016 41 minutes ago
The clown show here is futile, just a couple of dummies believing in the fake news to dump stock… a master class on stupidity and algorithmic manipulation painting a chart. Don’t listen to the clowns.
ICTY

Your Recent History

Delayed Upgrade Clock